Kampel, L.; Feldstein, S.; Tsuriel, S.; Hannes, V.; Carmel Neiderman, N.N.; Horowitz, G.; Warshavsky, A.; Leider-Trejo, L.; Hershkovitz, D.; Muhanna, N.
Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients. Biomolecules 2023, 13, 1418.
https://doi.org/10.3390/biom13091418
AMA Style
Kampel L, Feldstein S, Tsuriel S, Hannes V, Carmel Neiderman NN, Horowitz G, Warshavsky A, Leider-Trejo L, Hershkovitz D, Muhanna N.
Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients. Biomolecules. 2023; 13(9):1418.
https://doi.org/10.3390/biom13091418
Chicago/Turabian Style
Kampel, Liyona, Sara Feldstein, Shlomo Tsuriel, Victoria Hannes, Narin N. Carmel Neiderman, Gilad Horowitz, Anton Warshavsky, Leonor Leider-Trejo, Dov Hershkovitz, and Nidal Muhanna.
2023. "Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients" Biomolecules 13, no. 9: 1418.
https://doi.org/10.3390/biom13091418
APA Style
Kampel, L., Feldstein, S., Tsuriel, S., Hannes, V., Carmel Neiderman, N. N., Horowitz, G., Warshavsky, A., Leider-Trejo, L., Hershkovitz, D., & Muhanna, N.
(2023). Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients. Biomolecules, 13(9), 1418.
https://doi.org/10.3390/biom13091418
